Attune Pharmaceuticals Private
Attune Pharmaceuticals is a private biotechnology company focused on discovering and developing novel oral once-daily small-molecule therapeutics for the treatment of rare diseases.
Industry:
PharmTech
Last Funding Type:
Series B
Estimated Revenue:
$1M to $10M
Total Funding:
23000000
Investors Number:
6
Headquarters:
New York, New York, United States
Investor Type:
Early Stage Venture
Last Funding Date:
2019
Founded Date:
2018
Employee Number:
1-10